Literature DB >> 29062329

Dissemination and genetic support of broad-spectrum beta-lactam-resistant Escherichia coli strain isolated from two Tunisian hospitals during 2004-2012.

Khaoula Ayari1, Amel Bourouis1, Hela Chihi1, Sihem Mahrouki1, Thierry Naas2, Omrane Belhadj1.   

Abstract

BACKGROUND: The dissemination of extended-spectrum β-lactamase (ESBL)-producing bacteria presented a great concern worldwide. Gram-negative organisms such as Escherichia coli and Klebsiella pneumoniae are the most frequently isolated pathogens responsible for nosocomial infections.
OBJECTIVES: The aim of this study was to investigate and to follow the emergence of resistance and the characterization of Extended-Spectrum Beta-Lactamases (ESBL) among broad-spectrum beta-lactam-Escherichia coli clinical isolates recovered from the military hospital and Habib Thameur hospital in Tunisia.
METHODS: A total of 113 E.coli isolates obtained during the period 2004 through 2012 showed a significant degree of multi-resistance. Among these strains, the double-disk synergy test confirmed the ESBL phenotype in 46 isolates. These included 32(70%) strains from Hospital A and 14(30%) from Hospital B.
RESULTS: The ESBL was identified as CTX-M-15. The ESBL resistance was transferred by a 60 kb plasmid CTXM-15-producing isolates were unrelated according to the PFGE analysis and characterization of the regions surrounding the blaCTX-M-15 showed the ISEcp1 elements located in the upstream region of the bla gene and 20 of them truncated by IS26.
CONCLUSION: ESBL producing E. coli strains are a serious threat in the community in Tunisia and we should take into consideration any possible spread of such epidemiological resistance.

Entities:  

Keywords:  CTX-M-15; ESBLs; Escherichia coli; diverse clones

Mesh:

Substances:

Year:  2017        PMID: 29062329      PMCID: PMC5637019          DOI: 10.4314/ahs.v17i2.8

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  34 in total

1.  Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3.

Authors:  Laurent Poirel; Marek Gniadkowski; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

2.  DNA sequence analysis of the genetic environment of various blaCTX-M genes.

Authors:  C Eckert; V Gautier; G Arlet
Journal:  J Antimicrob Chemother       Date:  2005-11-16       Impact factor: 5.790

Review 3.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

4.  OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa.

Authors:  L N Philippon; T Naas; A T Bouthors; V Barakett; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

5.  Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate.

Authors:  P A Bradford; C E Cherubin; V Idemyor; B A Rasmussen; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

6.  Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli.

Authors:  G A Jacoby; P Han
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

7.  Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

Authors:  N Woodford; M E Ward; M E Kaufmann; J Turton; E J Fagan; D James; A P Johnson; R Pike; M Warner; T Cheasty; A Pearson; S Harry; J B Leach; A Loughrey; J A Lowes; R E Warren; D M Livermore
Journal:  J Antimicrob Chemother       Date:  2004-09-03       Impact factor: 5.790

8.  The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup.

Authors:  Olivier Clermont; Marie Lavollay; Sophie Vimont; Catherine Deschamps; Christiane Forestier; Catherine Branger; Erick Denamur; Guillaume Arlet
Journal:  J Antimicrob Chemother       Date:  2008-03-11       Impact factor: 5.790

9.  Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15.

Authors:  Teresa M Coque; Angela Novais; Alessandra Carattoli; Laurent Poirel; Johann Pitout; Luísa Peixe; Fernando Baquero; Rafael Cantón; Patrice Nordmann
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

10.  High rate of mobilization for blaCTX-Ms.

Authors:  Miriam Barlow; Rebecca A Reik; Stephen D Jacobs; Mónica Medina; Matthew P Meyer; John E McGowan; Fred C Tenover
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

View more
  1 in total

1.  Screening for Carbapenemases in Ertapenem-Resistant Enterobacteriaceae Collected at a Tunisian Hospital Between 2014 and 2018.

Authors:  Hans Kollenda; Hagen Frickmann; Rania Ben Helal; Dorothea Franziska Wiemer; Habiba Naija; Mohamed Sélim El Asli; Melanie Egold; Joachim Jakob Bugert; Susann Handrick; Roman Wölfel; Farouk Barguellil; Mohamed Ben Moussa
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2019-02-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.